 |
Omega-3 (n-3) polyunsaturated fatty acid with all double bonds in the cis configuration |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of organ graft rejection |
| USA Market Approval | USA |
| USA Designation Date | 1995-11-22 00:00:00 |
| Sponsor | Research Triangle Pharmaceuticals;4364 South Alston Avenue;Durham, North Carolina, 27713 |
